Загрузка...
Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors
Tumor-targeted drug delivery improves anti-tumor efficacy and reduces systemic toxicity by limiting bioavailability of cytotoxic drugs to within tumors. Targeting reagents, such as peptides or antibodies recognizing molecular targets over-expressed within tumors, have been used to improve liposome-e...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3044774/ https://ncbi.nlm.nih.gov/pubmed/21075152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2010.11.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|